Clinical trial
Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward
NCT00418873 · Astellas Pharma Inc, Industry · Terminated
Key facts
| NCT number | NCT00418873 |
|---|---|
| Title | Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward |
| Official title | A Multi-centre Comparative Study to Evaluate the Anti-aggression Effect and Safety of Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Collaborators | Astellas Pharma Taiwan, Inc. Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Zotepine, Risperidone |
| Enrollment | 39 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jan 5, 2007 |
| Last update posted | Apr 16, 2010 |
| Countries | Taiwan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: